DD106170A5 - - Google Patents

Info

Publication number
DD106170A5
DD106170A5 DD17023273A DD17023273A DD106170A5 DD 106170 A5 DD106170 A5 DD 106170A5 DD 17023273 A DD17023273 A DD 17023273A DD 17023273 A DD17023273 A DD 17023273A DD 106170 A5 DD106170 A5 DD 106170A5
Authority
DD
German Democratic Republic
Application number
DD17023273A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of DD106170A5 publication Critical patent/DD106170A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • C07D209/86Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • C07D209/88Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
DD17023273A 1972-05-25 1973-04-17 DD106170A5 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19722226703 DE2226703A1 (de) 1972-05-25 1972-05-25 Neue tetrahydrocarbazolderivate und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
DD106170A5 true DD106170A5 (ja) 1974-06-05

Family

ID=5846530

Family Applications (1)

Application Number Title Priority Date Filing Date
DD17023273A DD106170A5 (ja) 1972-05-25 1973-04-17

Country Status (12)

Country Link
JP (1) JPS4941367A (ja)
AT (1) AT323155B (ja)
AU (1) AU5607873A (ja)
BE (1) BE800066A (ja)
CA (1) CA1005062A (ja)
CH (1) CH582144A5 (ja)
CS (1) CS179416B2 (ja)
DD (1) DD106170A5 (ja)
DE (1) DE2226703A1 (ja)
FR (1) FR2185414B1 (ja)
GB (1) GB1436893A (ja)
NL (1) NL7307313A (ja)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235903A (en) * 1979-08-06 1980-11-25 American Home Products Corporation 1-Hydroxyalkanamine tetrahydrocarbazoles and cyclopent[b]indoles, compositions and method of use
US7151100B1 (en) 1999-07-23 2006-12-19 The Regents Of The University Of California Indole compounds useful for the treatment of cancer
US7105560B1 (en) 1999-07-23 2006-09-12 The Regents Of The University Of California Use of etodolac in the treatment of multiple myeloma
US6545034B1 (en) 1999-07-23 2003-04-08 The Regents Of The University Of California Use of etodolac for the treatment of chronic lymphocytic leukemia
US7129262B2 (en) 1999-07-23 2006-10-31 The Regents Of The University Of California Indole compounds useful for the treatment of cancer
US7361680B2 (en) 1999-07-23 2008-04-22 The Regents Of The University Of California Indole compounds useful for the treatment of cancer
DE10164564B4 (de) * 2001-12-14 2007-05-16 Zentaris Gmbh Tetrahydrocarbazolderivate als Liganden für G-Protein gekoppelte Rezeptoren (GPCR)
WO2004026116A2 (en) 2002-09-19 2004-04-01 The Regents Of The University Of California Use of etodoclac to treat hyperplasia
US20060074124A1 (en) * 2003-09-12 2006-04-06 Andrew Napper Methods of treating a disorder
EP1677794B1 (en) * 2003-09-12 2014-12-03 Elixir Pharmaceuticals, Inc. Methods of treating disorder
US7314886B2 (en) 2003-10-02 2008-01-01 Cephalon, Inc. Tetrahydropyrano-indole derivatives
KR20190004843A (ko) * 2008-07-23 2019-01-14 아레나 파마슈티칼스, 인크. 자가면역성 및 염증성의 장애의 치료에 유용한 치환된 1,2,3,4-테트라히드로시클로펜타[b]인돌-3-일)아세트산 유도체
BRPI0917923B1 (pt) 2008-08-27 2022-04-05 Arena Pharmaceuticals Inc Derivado de ácido tricíclico substituído, sua composição, seu uso e processo para preparar a referida composição
EP3378854B1 (en) 2010-01-27 2022-12-21 Arena Pharmaceuticals, Inc. Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof
JP2013521301A (ja) 2010-03-03 2013-06-10 アリーナ ファーマシューティカルズ, インコーポレイテッド S1p1受容体修飾物質およびその結晶形の調製のためのプロセス
CN116850181A (zh) 2015-01-06 2023-10-10 艾尼纳制药公司 治疗与s1p1受体有关的病症的方法
MX2017016530A (es) 2015-06-22 2018-03-12 Arena Pharm Inc Sal cristalina de l-arginina del acido (r)-2-(7-(4-ciclopentil-3-( trifluorometil)benciloxi)-1,2,3,4-tetrahidrociclopenta[b]indol-3- il)acetico (compuesto1) para ser utilizada en transtornos asociados con el receptor de esfingosina-1-fosfato 1 (s1p1).
US11478448B2 (en) 2017-02-16 2022-10-25 Arena Pharmaceuticals, Inc. Compounds and methods for treatment of inflammatory bowel disease with extra-intestinal manifestations
CN110520124A (zh) 2017-02-16 2019-11-29 艾尼纳制药公司 用于治疗原发性胆汁性胆管炎的化合物和方法
KR20210074291A (ko) 2018-09-06 2021-06-21 아레나 파마슈티칼스, 인크. 자가면역 및 염증성 장애의 치료에 유용한 화합물
CN114634442B (zh) * 2022-04-02 2023-10-13 内蒙古民族大学 一种四氢咔唑酮化合物的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH586678A5 (ja) * 1970-05-25 1977-04-15 Hoffmann La Roche
ZA715217B (en) * 1970-08-20 1972-04-26 Org Nv Anti-inflammatory preparations

Also Published As

Publication number Publication date
FR2185414A1 (ja) 1974-01-04
GB1436893A (en) 1976-05-26
CH582144A5 (ja) 1976-11-30
BE800066A (fr) 1973-11-26
DE2226703A1 (de) 1973-12-13
CS179416B2 (en) 1977-10-31
FR2185414B1 (ja) 1976-08-13
NL7307313A (ja) 1973-11-27
CA1005062A (en) 1977-02-08
AT323155B (de) 1975-06-25
AU5607873A (en) 1974-11-28
JPS4941367A (ja) 1974-04-18

Similar Documents

Publication Publication Date Title
JPS4944721A (ja)
FR2185414B1 (ja)
JPS4940048A (ja)
FR2182469A5 (ja)
JPS4929765A (ja)
JPS5256768Y2 (ja)
CS152733B1 (ja)
CS157994B1 (ja)
CS154504B1 (ja)
JPS495090U (ja)
JPS48110215U (ja)
JPS4914328U (ja)
CS152039B1 (ja)
CS156012B1 (ja)
CS156386B1 (ja)
CS156687B1 (ja)
CS155444B1 (ja)
CH572363A5 (ja)
CH577227A5 (ja)
CH574076A5 (ja)
CH573743A5 (ja)
CH573333A5 (ja)
CH572737A5 (ja)
CH574595A5 (ja)
CH575646A5 (ja)